These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date 2020-000047-31 A Randomized, Placebo-controlled, Double-blind, Parallel-group, Multicenter, Phase 2a Study of the Efficacy and Safety of Oral AMT-101 in Subjects with Moderate to Severe Ulcerative Colitis 2022-12-28 bad-data
Listed as ongoing, but also has a completion date 2020-000048-73 A Combined Phase 2 (12 Weeks)/Phase 3 (52 Weeks) Randomized, Double-blind, Placebo-controlled Multicenter Study Investigating the Efficacy and Safety of AMT-101 in Subjects with Chronic Pouchitis 2023-04-21 bad-data
Not reported 2020-002833-13 A Randomized, Placebo-controlled, Double-blind, Parallel-group, Exploratory, Phase 2 Study of the Efficacy and Safety of Oral AMT-101 in Combination with Adalimumab in Subjects with Moderate to Severe... 2022-07-13 due-trials
Completed, report not yet due Terminated 2020-003955-14 A Randomized, Double-blind, Placebo-controlled, Parallel Group, Exploratory Phase 2 Study of the Efficacy and Safety of Oral AMT-101 in Adults with Active Rheumatoid Arthritis who have demonstrated an... 2023-04-11 not-yet-due